Skip to main content
. 2021 Aug 26;2021:9998697. doi: 10.1155/2021/9998697

Figure 4.

Figure 4

Difference of immune cell abundance between COVID-19 patients and healthy people (a) ssGSEA for evaluation of 28 immune cell infiltration in GSE152641. (b) CIBERSORT for evaluation of 22 immune cell infiltration in GSE152641. (c) SsGSEA for evaluation of 28 immune cell infiltration in GSE161777. (d) CIBERSORT for evaluation of 22 immune cell infiltration in GSE161777.